Is intensive glycemic control worth the expense?
Eastman
R C
RC
Division of Diabetes, Endocrinology and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Disease, USA.
D000293:Adolescent; D000328:Adult; D001786:Blood Glucose / Q000032:analysis; D003362:Cost-Benefit Analysis; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy* / Q000191:economics*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy* / Q000191:economics*; D006801:Humans; D014481:United States
D001786:Blood Glucose